TABLE 2.
Group | Animal | Resulta for viral antigen:
|
|||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gag
|
Env
|
Pol
|
Accessory peptide
|
||||||||||||||
Primeb | Wk 0c | Wk 2 | Wk 4 | Prime | Wk 0 | Wk 2 | Wk 4 | Prime | Wk 0 | Wk 2 | Wk 4 | Prime | Wk 0 | Wk 2 | Wk 4 | ||
Control | J96258 | —d | 2 | NDe | 50 | — | 0 | ND | 90 | — | 2 | ND | 0 | — | 2 | ND | 0 |
J97167 | — | 5 | 10 | 25 | — | 5 | 0 | 40 | — | 5 | 35 | 5 | — | 15 | 0 | 25 | |
J97200 | — | 0 | 0 | 5 | — | 15 | 5 | 5 | — | 5 | 0 | 0 | — | 0 | 0 | 0 | |
J98071 | — | 0 | 5 | 10 | — | 0 | 10 | 0 | — | 0 | 0 | 10 | — | 0 | 0 | 0 | |
K96166 | — | 20 | 120f | 70 | — | 0 | 30 | 0 | — | 0 | 0 | 5 | — | 0 | 5 | 150 | |
K97107 | — | 0 | 100 | 55 | — | 5 | 0 | 10 | — | 0 | 5 | 10 | — | 0 | 20 | 0 | |
DNA-DNA | A98069 | 0 | 5 | 320 | 160 | 10 | 5 | 0 | 60 | 0 | 0 | ND | 0 | 5 | 10 | ND | 30 |
J97172 | 0 | 0 | 25 | 50 | 0 | 5 | 75 | 90 | 0 | 5 | 430 | 0 | 0 | 5 | 145 | 0 | |
J98124 | 0 | 0 | 75 | 100 | 0 | 0 | 560 | 0 | 0 | 0 | 0 | 20 | 5 | 0 | 5 | 5 | |
K97246 | 5 | 0 | 225 | 90 | 15 | 5 | 890 | 75 | 0 | 0 | 35 | 0 | 0 | 0 | 55 | 100 | |
K98220 | 0 | 0 | 60 | 0 | 5 | 0 | 345 | 25 | 0 | 5 | 25 | 0 | 0 | 0 | 630 | 0 | |
T97232 | 0 | 0 | 300 | 0 | 0 | 20 | 15 | 10 | 0 | 0 | 0 | 0 | 0 | 0 | 35 | 0 | |
DNA-particle | J97156 | 0 | 10 | ND | 0 | 0 | 0 | ND | 0 | 0 | 0 | ND | 0 | 0 | 0 | ND | 0 |
J97183 | 0 | 10 | 5 | 5 | 0 | 10 | 70 | 0 | 0 | 5 | 0 | 0 | 0 | 5 | 25 | 0 | |
J97205 | 0 | 15 | 595 | 120 | 0 | 0 | 180 | 0 | 0 | 0 | 0 | 0 | 0 | 5 | 35 | 0 | |
L96018 | 10 | 160 | 60 | 595 | 15 | 30 | 345 | 45 | 0 | 35 | 25 | 70 | 10 | 10 | 630 | 30 | |
T98098 | 5 | 0 | ND | 30 | 0 | 0 | ND | 10 | 10 | 0 | ND | 10 | 5 | 0 | ND | 15 | |
T98108 | 0 | 0 | 55 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 15 | 10 | 0 | 0 | 305 | 20 | |
DNA-vaccinia virus | A98061 | 5 | 398 | 1,090 | 230 | 20 | 362 | 500 | 220 | 15 | 0 | 1,300 | 0 | 0 | 0 | 15 | 70 |
J97240 | 0 | 90 | 910 | 180 | 0 | 300 | 130 | 1,485 | 0 | 0 | 10 | 15 | 0 | 0 | 0 | 0 | |
K97110 | 0 | 1,018 | 0 | 20 | 0 | 1,315 | 110 | 45 | 0 | 0 | 0 | 0 | 0 | 0 | 170 | 235 | |
K98097 | 0 | 10 | 705 | 445 | 0 | 15 | 670 | 520 | 0 | 0 | 0 | 0 | 0 | 15 | 0 | 0 | |
K98099 | 40 | 40 | ND | 10 | 65 | 145 | ND | 1,595 | 10 | 0 | ND | 0 | 55 | 0 | ND | 10 | |
L97191 | 10 | 325 | 875 | 30 | 0 | 255 | 70 | 50 | 0 | 0 | 0 | 0 | 0 | 0 | 205 | 35 | |
Vaccinia virus-DNA | J97168 | 0 | 25 | 100 | 145 | 10 | 15 | 0 | 25 | 10 | 0 | 0 | 25 | 10 | 10 | 5 | 65 |
J97266 | 0 | 20 | 440 | 235 | 55 | 440 | 205 | 230 | 0 | 0 | 0 | 0 | 5 | 0 | 0 | 0 | |
K97129 | 10 | 210 | 430 | 185 | 10 | 635 | 5 | 925 | 0 | 22 | 0 | 5 | 0 | 10 | 0 | 110 | |
K98157 | 0 | 10 | 230 | 150 | 10 | 15 | 1,425 | 10 | 0 | 0 | 15 | 10 | 0 | 0 | 95 | 0 | |
L98152 | 215 | 85 | 815 | 280 | 35 | 35 | 455 | 10 | 5 | 5 | 15 | 0 | 0 | 0 | 10 | 10 | |
Z96290 | 310 | 90 | 70 | 5 | 210 | 575 | 470 | 15 | 90 | 0 | 0 | 5 | 135 | 0 | 5 | 5 |
Spot-forming cells/106 PBMC measured by IFN-γ ELISpot with pools of overlapping peptides.
Prime, samples taken after 3 doses of DNA or 2 doses of recombinant vaccinia virus.
Wk 0, day of challenge (3 weeks after the last boosting dose).
—, Not applicable.
ND, not determined.
Numbers in boldface type are >2 times the background for that animal and >40 spot-forming cells/106 PBMC.